Efficacy and safety of escitalopram versus citalopram in major depressive disorder: A 6-week, multicenter, randomized, double-blind, flexible-dose study

Psychopharmacology

Volumn 213, Issue 2-3, 2011, Pages 639-646

  Ou, Jian Jun ^a   Xun, Guang Lei ^a   Wu, Ren Rong ^a   Li, Le Hua ^a   Fang, Mao Sheng ^a,b   Zhang, Hong Geng ^c   Xie, Shi Ping ^d   Shi, Jian Guo ^e   Du, Bo ^e   Yuan, Xue Qin ^f   Zhao, Jing Ping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Wu'han Mental Health Center   (China)

^c Hunan Brain Hospital   (China)

^d THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e SHANDONG MENTAL HEALTH CENTER   (China)

^f National Institutes of Pharmaceutical Research and Development   (China)

Author keywords

Citalopram; Double blind; Escitalopram; Major depressive disorder; Randomized

Indexed keywords

CITALOPRAM; ESCITALOPRAM;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTICLE; BURNING SENSATION; CHINESE; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HAMILTON SCALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RETCHING; SIDE EFFECT; STOMACH DISCOMFORT; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952484668     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1822-y     Document Type: Article

References (40)

1. APA (2000) Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association Am J Psychiatry 157:1-45
2. Auquier P, Robitail S, Llorca PM, Rive B (2003) Comparison of escitalopram and citalopram efficacy: A meta-analysis. Int J Psychiatry Clin Pract 7:259-268 (Pubitemid 37462224)
3. Azorin JM, Llorca PM, Despiegel N, Verpillat P (2004) Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder. Encephale 30:158-66 (Pubitemid 38647748)
4. Baldwin DS, Cooper JA, Huusom AK, Hindmarch I (2006) A doubleblind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder. Int Clin Psychopharmacol 21:159-69 (Pubitemid 43740307)
5. Baldwin DS, Montgomery SA, Nil R, Lader M (2007a) Discontinuation symptoms in depression and anxiety disorders. Int J Neuropsychopharmacol 10:73-84 (Pubitemid 46122754)
6. Baldwin DS, Reines EH, Guiton C, Weiller E (2007b) Escitalopram therapy for major depression and anxiety disorders. Ann Pharmacother 41:1583-1592 (Pubitemid 47485624)
7. Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M (2006) A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients. Curr Med Res Opin 22:1331-1341 (Pubitemid 44085585)
8. Burke WJ, Gergel I, Bose A (2002) Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 63:331-336 (Pubitemid 34456361)
9. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JPT, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C (2009a) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373:746-758
10. Cipriani A, Santilli C, Furukawa TA, Signoretti A, Nakagawa A, McGuire H, Churchill R, Barbui C (2009b) Escitalopram versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews
11. Colonna L, Andersen HF, Reines EH (2005) A randomized, doubleblind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder. Curr Med Res Opin 21:1659-68 (Pubitemid 41505032)
12. Demyttenaere K, Hemels ME, Hudry J, Annemans L (2005) A cost-effectiveness model of escitalopram, citalopram, and venlafaxine as first-line treatment for major depressive disorder in Belgium. Clin Ther 27:111-24 (Pubitemid 40342582)
13. Esposito D, Wahl P, Daniel G, Stoto MA, Erder MH, Croghan TW (2009) Results of a Retrospective Claims Database Analysis of Differences in Antidepressant Treatment Persistence Associated With Escitalopram and Other Selective Serotonin Reuptake Inhibitors in the United States. Clin Ther 31:644-656
14. Fantino B, Moore N, Verdoux H, Auray JP (2007) Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder. Int Clin Psychopharmacol 22:107-15
15. Francois C, Toumi M, Aakhus AM, Hansen K (2003) A pharmacoeconomic evaluation of escitalopram, a new selective serotonin reuptake inhibitor. Comparison of cost-effectiveness between escitalopram, citalopram, fluoxetine, and venlafaxine for the treatment of depression in Norway. Eur J Health Econ 4:12-9 (Pubitemid 36457052)
16. Gorman JM, Korotzer A, Su GJ (2002) Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials. Cns Spectrums 7:40-44 (Pubitemid 34663207)
17. Gorwood P, Weiller E, Lemming O, Katona C (2007) Escitalopram prevents relapse in older patients with major depressive disorder. Am J Geriatr Psychiatry 15:581-93
18. Hakanson R (2002) The preclinical observation that escitalopram possesses a faster time to onset of efficacy than citalopram. Pharmacol Toxicol 90:3-4
19. Kasper S, Baldwin DS, Lonn SL, Boulenger JP (2009) Superiority of escitalopram to paroxetine in the treatment of depression. European Neuropsychopharmacology 19:229-237
20. Kasper S, Lemming OM, de Swart H (2006a) Escitalopram in the long-term treatment of major depressive disorder in elderly patients. Neuropsychobiology 54:152-9
21. Kasper S, Spadone C, Verpillat P, Angst J (2006b) Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis. Int Clin Psychopharmacol 21:105-10 (Pubitemid 43740318)
22. Kennedy SH, Andersen HF, Lam RW (2006) Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. J Psychiatry Neurosci 31:122-131
23. Kennedy SH, Andersen HF, Thase ME (2009) Escitalopram in the treatment of major depressive disorder: A meta-analysis. Curr Med Res Opin 25:161-175
24. Lalit V, Appaya PM, Hegde RP et al (2004) Escitalopram versus citalopram and sertraline: A double-blind controlled, multicentric trial in Indian patients with unipolar major depression. Ind J Psychiatry 46:333-341 (Pubitemid 40233853)
25. Lam RW, Andersen HF (2006) The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: an extended analysis. Pharmacopsychiatry 39:180-4 (Pubitemid 44369178)
26. Lancon C, Sapin C, Note I, Farisse J (2006) Comparison of escitalopram and citalopram in outpatients with severe major depressive disorder: a prospective, naturalistic, 8-week study. Int J Psychiatry Clin Pract 10:131-137 (Pubitemid 43879978)
27. Lepola U, Wade A, Andersen HF (2004) Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder. Int Clin Psychopharmacol 19:149-155 (Pubitemid 38586486)
28. Lepola UM, Loft H, Reines EH (2003) Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 18:211-217 (Pubitemid 36871872)
29. Llorca PM, Azorin JM, Despiegel N, Verpillat P (2005) Efficacy of escitalopram in patients with severe depression: a pooled analysis. Int J Clin Pract 59:268-75 (Pubitemid 40352741)
30. Moller HJ, Langer S, Schmauss M (2007) Escitalopram in clinical practice: Results of an open-label trial in outpatients with depression in a naturalistic setting in Germany. Pharmacopsychiatry 40:53-57 (Pubitemid 46697675)
31. Moore N, Verdoux H, Fantino B (2005) Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder (vol 21, pg 131, 2005). Int Clin Psychopharmacol 20:242-242
32. Rapaport MH, Bose A, Zheng H (2004) Escitalopram continuation treatment prevents relapse of depressive episodes. J Clin Psychiatry 65:44-9
33. Rush AJ, Bose A (2005) Escitalopram in clinical practice: Results of an open-label trial in a naturalistic setting. Depress Anxiety 21:26-32 (Pubitemid 40614546)
34. Stamouli SS, Yfantis A, Lamboussis E, Liakouras A, Lagari V, Tzanakaki M, Giailoglou D, Legault M, Parashos IA (2009) Escitalopram in clinical practice in Greece: treatment response and tolerability in depressed patients. Expert Opin Pharmacother 10:937-945
35. Svensson S, Mansfield PR (2004) Escitalopram: superior to citalopram or a chiral chimera? Psychother Psychosom 73:10-6
36. Wade A, Despiegel N, Heldbo Reines E (2006) Escitalopram in the long-term treatment of major depressive disorder. Ann Clin Psychiatry 18:83-9 (Pubitemid 43879895)
37. Wade AG, Toumi I, Hemels ME (2005) A probabilistic costeffectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK. Curr Med Res Opin 21:631-42
38. Wu E, Greenberg PE, Yang E, Yu A, Erder MH (2008) Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population. Curr Med Res Opin 24:2587-95
39. Wu EQ, Greenberg PE, Yang E, Yu AP, Ben-Hamadi R, Haim Erder M (2009) Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs. J Med Econ 12:124-35
40. Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV (2007) Efficacy and tolerability of Escitalopram versus citalopram in major depressive disorder: A 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Clin Ther 29:2319-2332 (Pubitemid 350302036)